FI93118B - Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI93118B FI93118B FI893250A FI893250A FI93118B FI 93118 B FI93118 B FI 93118B FI 893250 A FI893250 A FI 893250A FI 893250 A FI893250 A FI 893250A FI 93118 B FI93118 B FI 93118B
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- new therapeutically
- diazepine derivatives
- diazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8801716 | 1988-07-07 | ||
| NL8801716 | 1988-07-07 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI893250A0 FI893250A0 (fi) | 1989-07-04 |
| FI893250A FI893250A (fi) | 1990-01-08 |
| FI93118B true FI93118B (fi) | 1994-11-15 |
| FI93118C FI93118C (fi) | 1995-02-27 |
Family
ID=19852585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI893250A FI93118C (fi) | 1988-07-07 | 1989-07-04 | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US4985423A (fi) |
| EP (1) | EP0350131A3 (fi) |
| JP (1) | JPH0259582A (fi) |
| KR (1) | KR900001696A (fi) |
| CN (1) | CN1028408C (fi) |
| AU (1) | AU626892B2 (fi) |
| CA (1) | CA1315781C (fi) |
| DK (1) | DK330689A (fi) |
| FI (1) | FI93118C (fi) |
| HU (1) | HU204528B (fi) |
| IL (1) | IL90865A (fi) |
| NO (1) | NO170282C (fi) |
| NZ (1) | NZ229815A (fi) |
| PT (1) | PT91052B (fi) |
| TW (1) | TW219896B (fi) |
| ZA (1) | ZA895086B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015904D0 (en) * | 2000-06-28 | 2000-08-23 | Hoffmann La Roche | Inhibitors of HPV E1 helicase enzyme |
| DE10312969A1 (de) * | 2003-03-24 | 2004-10-07 | Bayer Healthcare Ag | Benzofuro-1,4-diazepin-2-on-Derivate |
| WO2009049362A1 (en) * | 2007-10-15 | 2009-04-23 | Monash University | A1 adenosine receptor allosteric enhancers |
| WO2015088565A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910887A (en) * | 1972-12-07 | 1975-10-07 | Degussa | Azabenzo-1,5-diazepines |
| US4404137A (en) * | 1979-10-16 | 1983-09-13 | Lilly Industries Limited | Pyrazolo [3,4-b][1,5]benzodiazepine compounds |
| GB8409960D0 (en) * | 1984-04-17 | 1984-05-31 | Searle & Co | Therapeutic method |
| US5087625A (en) * | 1990-10-19 | 1992-02-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pyridodiazepines and their use in the prevention or treatment of HIV infection |
-
1989
- 1989-06-29 TW TW078105024A patent/TW219896B/zh active
- 1989-07-03 US US07/374,775 patent/US4985423A/en not_active Expired - Fee Related
- 1989-07-03 EP EP19890201772 patent/EP0350131A3/en not_active Withdrawn
- 1989-07-03 HU HU893357A patent/HU204528B/hu not_active IP Right Cessation
- 1989-07-04 PT PT91052A patent/PT91052B/pt not_active IP Right Cessation
- 1989-07-04 NZ NZ229815A patent/NZ229815A/en unknown
- 1989-07-04 CA CA000604676A patent/CA1315781C/en not_active Expired - Fee Related
- 1989-07-04 IL IL9086589A patent/IL90865A/en not_active IP Right Cessation
- 1989-07-04 DK DK330689A patent/DK330689A/da not_active Application Discontinuation
- 1989-07-04 KR KR1019890009460A patent/KR900001696A/ko not_active Application Discontinuation
- 1989-07-04 CN CN89106718A patent/CN1028408C/zh not_active Expired - Fee Related
- 1989-07-04 FI FI893250A patent/FI93118C/fi not_active IP Right Cessation
- 1989-07-04 ZA ZA895086A patent/ZA895086B/xx unknown
- 1989-07-04 NO NO892772A patent/NO170282C/no unknown
- 1989-07-07 AU AU37954/89A patent/AU626892B2/en not_active Ceased
- 1989-07-07 JP JP1174331A patent/JPH0259582A/ja active Pending
-
1990
- 1990-12-11 US US07/625,441 patent/US5140024A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1028408C (zh) | 1995-05-17 |
| FI93118C (fi) | 1995-02-27 |
| FI893250A0 (fi) | 1989-07-04 |
| FI893250A (fi) | 1990-01-08 |
| US4985423A (en) | 1991-01-15 |
| NO892772D0 (no) | 1989-07-04 |
| PT91052A (pt) | 1990-02-08 |
| NO170282B (no) | 1992-06-22 |
| JPH0259582A (ja) | 1990-02-28 |
| CA1315781C (en) | 1993-04-06 |
| DK330689D0 (da) | 1989-07-04 |
| EP0350131A3 (en) | 1991-07-10 |
| IL90865A0 (en) | 1990-02-09 |
| TW219896B (fi) | 1994-02-01 |
| NO170282C (no) | 1992-09-30 |
| AU626892B2 (en) | 1992-08-13 |
| NO892772L (no) | 1990-01-08 |
| DK330689A (da) | 1990-01-08 |
| PT91052B (pt) | 1995-01-31 |
| AU3795489A (en) | 1990-01-11 |
| NZ229815A (en) | 1992-03-26 |
| US5140024A (en) | 1992-08-18 |
| IL90865A (en) | 1994-02-27 |
| KR900001696A (ko) | 1990-02-27 |
| ZA895086B (en) | 1990-05-30 |
| EP0350131A2 (en) | 1990-01-10 |
| HU204528B (en) | 1992-01-28 |
| CN1040027A (zh) | 1990-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| FI104170B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi | |
| FI874459A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi | |
| FI890245A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-disubstituoitujen piperidinyylijohdannaisten valmistamiseksi | |
| FI895417A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi | |
| FI92696C (fi) | Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi | |
| FI873350A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI883672A (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
| FI880467A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| FI893003A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
| FI892948A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| FI95701C (fi) | Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| FI92825C (fi) | Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| FI903431A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| FI911420A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi | |
| FI893002A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi | |
| FI895662A0 (fi) | Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi | |
| FI892420A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi | |
| FI973644A0 (fi) | Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi | |
| FI884473A (fi) | Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi | |
| FI893434A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi | |
| FI93118B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi | |
| FI93216C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| FI891111A (fi) | Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI97542B (fi) | Uusi menetelmä 9-amino-1,2,3,4-tetrahydroakridiinien valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: DUPHAR INTERNATIONAL RESEARCH B.V |